Analysis of Serum Metabolic Profiles in Women with Endometrial Cancer and Controls in a Population-Based Case-Control Study
Author(s) -
Mia M. Gaudet,
Roni T. Falk,
Robert Stevens,
Marc J. Gunter,
James R. Bain,
Ruth M. Pfeiffer,
Nancy Potischman,
Jolanta Lissowska,
Beata Pepłońska,
Louise A. Brinton,
Montserrat GarcíaClosas,
Christopher B. Newgard,
Mark E. Sherman
Publication year - 2012
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-1490
Subject(s) - odds ratio , endometrial cancer , medicine , endocrinology , case control study , metabolite , body mass index , population , confidence interval , quartile , cancer , gynecology , environmental health
Endometrial cancer is associated with metabolic disturbances related to its underlying risk factors, including obesity and diabetes. Identifying metabolite biomarkers associated with endometrial cancer may have value for early detection, risk assessment, and understanding etiology.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom